Merge Healthcare CEO Resigns Following Poor Second Quarter Sales | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Merge Healthcare CEO Resigns Following Poor Second Quarter Sales

August 9, 2013
by Rajiv Leventhal
| Reprints

Merge Healthcare, the Chicago-based provider of clinical systems, has announced that its CEO, Jeffery Surges, has resigned following a disappointing financial performance in its second quarter.

Merge reported that its sales decreased to $57.2 million ($57.6 million on a pro forma basis) in the second quarter of 2013, from $62.9 million ($63.4 million on a pro forma basis) in the second quarter of 2012.

"Speaking on behalf of all of Merge's directors, I want to apologize for the company's very disappointing second quarter results," Michael Ferro, Jr., Merge's chairman of the board and largest shareholder, said in a statement. "We all strongly believe in the company, its products and its employees."

Merge has appointed Justin Dearborn, who joined the company in 2008, as its new CEO. It also promoted Nancy Koenig to chief operating officer. Dearborn has served as CEO, CFO, and most recently as president and CEO of Merge's DNA reporting segment.

"Merge's value proposition continues to be very strong in three distinct market areas: imaging and interoperability, cardiology, and clinical trials," Dearborn said in a statement. "Our spending, on bringing innovative solutions to market, has outpaced our end user markets' readiness for a variety of macro-economic reasons currently clouding hospital spend decision making. We saw a continued reluctance amongst large health systems to move forward with enterprise purchases. Unfortunately, this pause has overshadowed the fourth quarter in a row of very strong bookings and revenue growth from our clinical trials group."

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).